Evidence map›Paper›PMID 18925574›Full record

ArticleThe Journal of comparative neurology2008

Sustained delivery of NT-3 from lens fiber cells in transgenic mice reveals specificity of neuroprotection in retinal degenerations.

Matthew M Lavail, Shimpei Nishikawa, Jacque L Duncan, Haidong Yang, Michael T Matthes, Douglas Yasumura, Douglas Vollrath, Paul A Overbeek, John D Ash, Michael L Robinson

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of comparative neurology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Overexpression of neurotrophin-3 stimulates a second wave of dopaminergic amacrine cell genesis after birth in the mouse retina.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2011
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Matthew M LavailBeckman Vision Center, University of California, San Francisco, San Francisco, California 94143-0730, USA.
Shimpei Nishikawa
Jacque L Duncan
Haidong Yang
Michael T Matthes
Douglas Yasumura
Douglas Vollrath
Paul A Overbeek
John D Ash
Michael L Robinson
University of California, San Francisco · USBaylor College of Medicine · USMiami University · USStanford University · USUniversity of Oklahoma Health Sciences Center · US

Funding

Rapid-Prototyping and Design CoreP30EY002162 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ULLIAN, ERIK M · 1985 to 2024
$16.8M
CELLULAR MECHANISMS OF INHERITED RETINAL DEGENERATIONR01EY001919 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LAVAIL, MATTHEW M · 1985 to 2014
$8.3M
THE ROLE OF FGF RECPETORS IN LENS DEVELOPMENTR01EY012995 · NEI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI ROBINSON, MICHAEL L · 2000 to 2018
$4.9M
Cytokine Regulation of Photoreceptor Gene ExpressionR01EY016459 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI ASH, JOHN D · 2006 to 2017
$4.0M
Neuronal networks for control of eye movementZ01EY000415 · NEI · NATIONAL EYE INSTITUTE · PI HIKOSAKA, OKIHIDE · 2003 to 2008
$2.3M
THERAPY FOR DOMINANTLY INHERITED RETINAL DEGENERATIONSK08EY000415 · NEI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI DUNCAN, JACQUE L · 2000 to 2004
$684k
Genetic model of retinal pigment epithelium degenerationR03EY014650 · NEI · STANFORD UNIVERSITY · PI VOLLRATH, DOUGLAS E. · 2003 to 2005
$480k
CELLULAR MECHANISMS OF INHERITED RETINAL DEGENERATIONR37EY001919 · NEI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI LAVAIL, MATTHEW M · 1989 to 1998
–
Intramural NIH HHS Z01 EY000415NEI NIH HHS EY01919NEI NIH HHS EY02162NEI NIH HHS EY12995NEI NIH HHS EY14650NEI NIH HHS K08 EY000415NEI NIH HHS P30 EY002162NEI NIH HHS R01 EY001919NEI NIH HHS R01 EY012995NEI NIH HHS R01 EY016459NEI NIH HHS R03 EY014650
6 · The paper itself

Abstract

Several neurotrophic factors (NTFs) are effective in protecting retinal photoreceptor cells from the damaging effects of constant light and slowing the rate of inherited photoreceptor degenerations. It is currently unclear whether, if continuously available, all NTFs can be protective for many or most retinal degenerations (RDs). We used transgenic mice that continuously overexpress the neurotrophin NT-3 from lens fibers under the control of the alphaA-crystallin promoter to test for neuroprotection in light-damage experiments and in four naturally occurring or transgenically induced RDs in mice. Lens-specific expression of NT-3 mRNA was demonstrated both by in situ hybridization in embryos and by reverse-transcriptase polymerase chain reaction (RT-PCR) in adult mice. Furthermore, NT-3 protein was found in abundance in the lens, ocular fluids, and retina by enzyme-linked immunosorbent assay (ELISA) and immunocytochemistry. Overexpression of NT-3 had no adverse effects on the structure or function of the retina for up to at least 14 months of age. Mice expressing the NT-3 transgene were protected from the damaging effects of constant light to a much greater degree than those receiving bolus injections of NT-3. When the NT-3 transgene was transferred into rd/rd, Rds/+, Q344ter mutant rhodopsin or Mertk knockout mice, overexpression of NT-3 had no protective effect on the RDs in these mice. Thus, specificity of the neuroprotective effect of NT-3 is clearly demonstrated, and different molecular mechanisms are inferred to mediate the protective effect in light-induced and inherited RDs.

Indexed as

Animalsc-Mer Tyrosine KinaseCytoprotectionEnzyme-Linked Immunosorbent AssayEpithelial CellsImmunohistochemistryLens, CrystallineLightMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutMice, Mutant StrainsMice, TransgenicNeurotrophin 3Photoreceptor Cells, Vertebratec-Mer Tyrosine KinaseMertk protein, mouseNeurotrophin 3Proto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesRNA, Messenger

Identifiers

PMID18925574
PMCPMC2702994
OpenAlexW2051341164

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.